                  In the United States Court of Federal Claims
                                     OFFICE OF SPECIAL MASTERS
                                            Filed: August 29, 2019
                                Refiled in Redacted Form: September 24, 2019

* * *         *    *   *    *    *    *   *    *    *    *
A.H.,                                                    *        UNPUBLISHED
                                                         *
                   Petitioner,                           *        No. 16-934V
                                                         *
v.                                                       *        Special Master Gowen
                                                         *
SECRETARY OF HEALTH                                      *        Motion for Dismissal Decision; Meningo-
AND HUMAN SERVICES,                                      *        coccal; Tetanus-Diphtheria-acellular
                                                         *        Pertussis (“DTaP”); Human Papillomavirus
                   Respondent.                           *        (“HPV”); Varicella; Autoimmune Dys-
                                                         *        Autonomia; Postural Orthostatic Tachy-
*    * *      *    *   *    *    *    *   *    *    *    *        cardia Syndrome (“POTS”).

Robert J. Krakow, Law Office of Robert J. Krakow, P.C., New York, NY, for petitioner.
Colleen C. Hartley, United States Department of Justice, Washington, DC, for respondent.

                                                     DECISION1

        On August 3, 2016, A.H. (“petitioner”) filed a petition in the National Vaccine Injury
Compensation Program.2 Petition (ECF No. 1). Petitioner alleged that she suffered autoimmune
dysautonomia, postural orthostatic tachycardia syndrome (“POTS”), and other conditions and
injuries as a result of meningococcal and tetanus-diphtheria-acellular pertussis (“DTaP”)
vaccines that she received on August 5, 2013. Id. Petitioner further alleges that those injuries
were caused and/or significantly aggravated by human papillomavirus (“HPV”) and varicella
vaccines that she received on August 5, 2014. Id. The information in the record, does not
establish entitlement to compensation.

        On August 28, 2019, petitioner filed a motion for a decision dismissing the petition.
Petitioner’s Motion (“Pet. Mot.”) (ECF No. 95). Petitioner avers that a full investigation has

1
  When this opinion was originally filed, I advised the parties of my intent to post it on the website of the United
States Court of Federal Claims (http://www.uscfc.uscourts.gov/aggregator/sources/7), in accordance with the E-
Government Act of 2002, see 44 U.S.C. § 3501 note (2012). In accordance with Vaccine Rule 18(b), petitioner
timely filed a motion to redact certain information, which I granted. This decision is being reissued with minimal
changes, namely the redaction of petitioner’s name to initials in the case caption and in the first line of the decision.
Other than those changes and this footnote, no other substantive changes have been made. This decision will be
posted on the Court’s website with no further opportunity to move for redaction.
2
 The Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, 42 U.S.C. §§ 300aa-10 et
seq. (hereinafter “Vaccine Act” or “the Act”). Hereafter, individual section references will be to 42 U.S.C. § 300aa
of the Act.
demonstrated that she will be unable to prove that she is entitled to compensation in the Vaccine
Program. Id. at ¶ 1. “In these circumstances, to proceed further would be unreasonable and
would waste the resources of the Court, the respondent, the petitioner, and the Vaccine
Program.” Id. at ¶ 2. Petitioner understands that a decision by the special master dismissing her
petition will result in a judgment against her and that such a judgment will end all of her rights in
the Vaccine Program. Id. at ¶ 3. Petitioner understands that she may apply for fees and costs
once the case is dismissed and judgment is entered against her. Id. at ¶ 4. Respondent expressly
reserves the right to question the good faith and reasonable basis of this claim and to oppose, if
appropriate, petitioner’s application for fees and costs. Respondent otherwise does not oppose
the motion. Petitioner intends to protect her rights to file a civil action in the future. Therefore,
pursuant to Section 21(a)(2), petitioner intends to elect to reject the Vaccine Program judgment
and elect to file a civil action. Id. at ¶ 5.

         To receive compensation in the Vaccine Program, petitioner has the burden of proving
either: (1) that petitioner suffered a “Table Injury,” i.e., an injury beginning within a specified
period of time following receipt of a corresponding vaccine listed on the Vaccine Injury Table (a
“Table injury”) or (2) that petitioner suffered an injury that was caused-in-fact by a covered
vaccine. §§ 13(a)(1)(A); 11(c)(1). Moreover, under the Vaccine Act, the Vaccine Program may
not award compensation based on petitioner’s claims alone. Rather, petitioner must support the
claim with either medical records or the opinion of a competent medical expert. § 13(a)(1). In
this case, petitioner has not alleged nor does the record reflect a Table injury. With regard to an
off-Table injury, petitioner has not provided medical records or expert opinion(s) which support
a finding of entitlement. Accordingly, petitioner has not met her burden of proof.

       Thus, petitioner’s motion is GRANTED. This matter is DISMISSED for insufficient
proof. The Clerk of the Court shall enter judgment accordingly.3

        IT IS SO ORDERED.
                                                                       s/Thomas L. Gowen
                                                                       Thomas L. Gowen
                                                                       Special Master




3
 Entry of judgment is expedited by each party’s filing notice renouncing the right to seek review. Vaccine Rule
11(a).

                                                         2
